Man, 43, left with a 'huge' hole in his face after being diagnosed with eye cancer
Daniel Jackson, from Margate in Kent, went to his GP after two months of struggling with a watery and irritated eye, which turned out to be ethmoid sinus cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - October 21, 2021 Category: Consumer Health News Source Type: news

Is Ocular Melanoma Same as Uveal Melanoma?
Title: Is Ocular Melanoma Same as Uveal Melanoma?Category: Diseases and ConditionsCreated: 10/4/2021 12:00:00 AMLast Editorial Review: 10/4/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 4, 2021 Category: Cancer & Oncology Source Type: news

Survival Up With Tebentafusp in Metastatic Uveal Melanoma
Overall survival longer with tebentafusp for HLA*02:01 - positive patients with previously untreated metastatic uveal melanoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 23, 2021 Category: Cancer & Oncology Tags: Oncology, Ophthalmology, Pharmacy, Journal, Source Type: news

Doctors identify an eye cancer culprit
Researchers have identified a molecular mechanism that drives the progression of uveal melanoma, an often lethal eye cancer in adults. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 13, 2021 Category: Universities & Medical Training Source Type: news

iPhone Flash Helps Nurse Identify Her Infant Son's Retinoblastoma iPhone Flash Helps Nurse Identify Her Infant Son's Retinoblastoma
An inadvertent flash exposed an unusual glow in her son's right eye. Now, a smartphone app can help parents identify possible eye disorders early.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 27, 2021 Category: Consumer Health News Tags: Nursing News Source Type: news

Melanoma of the eye: Preclinical tests show path toward treatment
(University of Alabama at Birmingham) A preclinical study offers hope for treatment of uveal melanoma, a rare and deadly cancer of the eye. A small molecule inhibitor has been identified that dampens the potent drivers of this tumor. In mouse models, the inhibitor strongly limited primary disease in the eye and metastatic tumor dissemination to the liver, and animals survived longer, without overt side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 14, 2021 Category: Cancer & Oncology Source Type: news

Oncotarget: Piperlongumine promotes death of retinoblastoma cancer cells
(Impact Journals LLC) These Oncotarget findings suggest that PL reduces tumor growth and induces cell death by regulating the cell cycle (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 31, 2021 Category: Cancer & Oncology Source Type: news

Small uveal melanomas 'not always harmless', ground breaking study finds
(University of Liverpool) A new article from Liverpool ocular researchers demonstrates that small uveal (intraocular) melanomas are not always harmless, as the current paradigm suggests. Instead, a reasonable proportion of them have molecular genetic alterations, which categorises them as highly metastatic tumours. The article recommends that they should not be observed but rather treated immediately, to improve patients' chances of survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 19, 2021 Category: Cancer & Oncology Source Type: news

By age 10, retinoblastoma patients' learning and life skills rebound
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital researchers studied how retinoblastoma survivors fared years later at home and at school. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 6, 2021 Category: Cancer & Oncology Source Type: news

New Hope Against a Rare but Incurable Eye Cancer
A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye. (Source: WebMD Health)
Source: WebMD Health - April 20, 2021 Category: Consumer Health News Source Type: news

New Hope Against a Rare but Incurable Eye Cancer
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 20, 2021 Category: Cancer & Oncology Tags: Family Medicine, Nursing, Oncology, Ophthalmology, Pharmacy, Research, News, Source Type: news

New Hope Against a Rare but Incurable Eye Cancer
TUESDAY, April 20, 2021 -- A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye, new clinical trial data show. Tebentafusp has now become the first drug shown to improve... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 20, 2021 Category: General Medicine Source Type: news

New Hope Against a Rare but Incurable Eye Cancer
Title: New Hope Against a Rare but Incurable Eye CancerCategory: Health NewsCreated: 4/20/2021 12:00:00 AMLast Editorial Review: 4/20/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 20, 2021 Category: Cancer & Oncology Source Type: news

Tebentafusp improves OS: A First in Metastatic Uveal Melanoma Tebentafusp improves OS: A First in Metastatic Uveal Melanoma
First-line tebentafusp significantly improved overall survival (OS) when compared with immunotherapy or chemotherapy in patients with metastatic uveal melanoma in a phase 3 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Penn spinout Linnaeus Therapeutics gets key FDA designation
A South Jersey biopharmaceutical firm spun out of the University of Pennsylvania got a boost Thursday when the Food and Drug Administration granted orphan drug designation for the company's lead new drug candidate. Linnaeus Therapeutics of Haddonfield received the designation for LNS8801. The experimental treatment is for patients with metastatic uveal melanoma, a rare cancer that occurs within the eye. The FDA's Office of Orphan Drug Products grants orphan status to support drug candidates targeting… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 12, 2021 Category: Biotechnology Authors: John George Source Type: news

Conjunctival Melanoma May Be Attributed to UV  Radiation Conjunctival Melanoma May Be Attributed to UV  Radiation
According to a new study published in Nature Communications, exposure to ultraviolet radiation can lead to a rare type of eye cancer called conjunctival melanoma.Medscape News UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 13, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Huntsman Cancer Institute researchers identify promising drug combination for melanoma
This study was published in the journalClinical Cancer Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 3, 2020 Category: Cancer & Oncology Source Type: news

Eye cancer: Shadows, flashes of light, or wiggly lines in your vision could be early signs
EYE cancer is a general term that includes different cancer types with different parts of the eye. Knowing the early signs of the disease will allow for earlier treatment. What to look out for? (Source: Daily Express - Health)
Source: Daily Express - Health - November 27, 2020 Category: Consumer Health News Source Type: news

What Is the Survival Rate of Retinoblastoma?
Title: What Is the Survival Rate of Retinoblastoma?Category: Diseases and ConditionsCreated: 10/22/2020 12:00:00 AMLast Editorial Review: 10/22/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 22, 2020 Category: Cancer & Oncology Source Type: news

Does Retinoblastoma Cause Blindness?
Title: Does Retinoblastoma Cause Blindness?Category: Diseases and ConditionsCreated: 10/21/2020 12:00:00 AMLast Editorial Review: 10/21/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 21, 2020 Category: Cancer & Oncology Source Type: news

Therapy using immune system cells preserves vision in mice implanted with rare eye cancer
(UNC Lineberger Comprehensive Cancer Center) A treatment that uses immune system T cells, combined with an immune-boosting drug packaged in an injectable gel, was found to preserve the vision of mice implanted with retinoblastoma tissue. The cancer, which is most commonly diagnosed in infants and young children, is treatable in early stages but can still lead to the loss of vision in about 5% of cases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 12, 2020 Category: Cancer & Oncology Source Type: news

Morris Animal Foundation awards nearly $1M in grants for new studies for equine health
(Morris Animal Foundation) Morris Animal Foundation, a leader in advancing animal health, has awarded nearly $1 million in large animal health research grants, supporting 14 projects. The studies will help veterinary scientists improve the well-being of horses through improved prevention and treatment of numerous health challenges, including eye cancer, heart arrhythmias and risks for injury from air transport. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 17, 2020 Category: International Medicine & Public Health Source Type: news

Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division
Cell size is fundamental to cell physiology. For example, cell size determines the spatial scale of organelles and intracellular transport and thereby affects biosynthesis. Although some genes that affect mammalian cell size have been identified, the molecular mechanisms through which cell growth drives cell division have remained elusive. We show that cell growth during the G1 phase of the cell division cycle dilutes the cell cycle inhibitor Retinoblastoma protein (Rb) to trigger division in human cells. RB overexpression increased cell size and G1 duration, whereas RB deletion decreased cell size and removed the inverse ...
Source: ScienceNOW - July 22, 2020 Category: Science Authors: Zatulovskiy, E., Zhang, S., Berenson, D. F., Topacio, B. R., Skotheim, J. M. Tags: Cell Biology, Engineering reports Source Type: news

Ophthalmologists Called to Catch Cancers Earlier Ophthalmologists Called to Catch Cancers Earlier
Advances in the management of common eye cancers have highlighted the need for early treatment, experts say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 17, 2020 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Missing BAP1 gene associated with immunosuppressive molecules in uveal melanoma
(University of Turku) New study from researchers in Finland and the United Kingdom reveals that tumors lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas (UM). The researchers also discovered that when BAP1 is lost, other molecules will be present in order to support cancer growth. Luckily, some of these molecules can be targeted with existing drugs, which can lead to the development of novel immunotherapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 9, 2020 Category: Cancer & Oncology Source Type: news

---
Three brothers under the age of five have been diagnosed with a type of rare eye cancer. HLN's Lynn Smith talks to the Rush family about how the boys are doing. (Source: CNN.com - Health)
Source: CNN.com - Health - February 12, 2020 Category: Consumer Health News Source Type: news

3 Brothers Have the Same Rare Cancer
The Rush brothers, ages 5 years, 4 years, and 7 months, share something that most brothers don’t: bilateral retinoblastoma, a rare eye cancer. See how their mother, who was also born with the disease, handles treatments, daily life, and facing the unknown. (Source: WebMD Health)
Source: WebMD Health - February 11, 2020 Category: Consumer Health News Source Type: news

Combination Treatments May Improve Survival for Patients with Metastatic Uveal Melanoma
The authors indicated that prospective clinical trials investigating DTIC-based systemic chemotherapies and liver-directed treatments are necessary to validate their findings. (Source: CancerNetwork)
Source: CancerNetwork - February 6, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Three Georgia brothers under six are all battling the same rare eye cancer
Brothers Tristan Rush, five; Caison Rush, three; and Carter Rush. six months, from Marietta, Georgia have all been diagnosed with retinoblastoma, a rare form of eye cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - February 4, 2020 Category: Consumer Health News Source Type: news

Shift in treatment modalities associated with improved outcomes in uveal melanoma patients with live
(Thomas Jefferson University) New retrospective study indicates that the shift of treatment from systemic chemotherapies to liver-directed therapies provides survival benefits. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 3, 2020 Category: Cancer & Oncology Source Type: news

p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
The p27 protein is a canonical negative regulator of cell proliferation and acts primarily by inhibiting cyclin-dependent kinases (CDKs). Under some circumstances, p27 is associated with active CDK4, but no mechanism for activation has been described. We found that p27, when phosphorylated by tyrosine kinases, allosterically activated CDK4 in complex with cyclin D1 (CDK4-CycD1). Structural and biochemical data revealed that binding of phosphorylated p27 (phosp27) to CDK4 altered the kinase adenosine triphosphate site to promote phosphorylation of the retinoblastoma tumor suppressor protein (Rb) and other substrates. Surpri...
Source: ScienceNOW - December 11, 2019 Category: Science Authors: Guiley, K. Z., Stevenson, J. W., Lou, K., Barkovich, K. J., Kumarasamy, V., Wijeratne, T. U., Bunch, K. L., Tripathi, S., Knudsen, E. S., Witkiewicz, A. K., Shokat, K. M., Rubin, S. M. Tags: Biochemistry, Medicine, Diseases, Online Only r-articles Source Type: news

Boy's rare eye cancer spotted in photograph
Noah Blanks, aged six, had an eye removed after being diagnosed with a rare form of cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 10, 2019 Category: Consumer Health News Source Type: news

Top Miami doctor is sued by three families of children whose eye cancer spread to their brains
Damian Creed and Salette Ruiz, patients of Dr Timothy Murray, died aged four and five in 2016 after their cancers spread. Jayden Alvarenga, six, now has brain damage after his cancer spread. (Source: the Mail online | Health)
Source: the Mail online | Health - November 27, 2019 Category: Consumer Health News Source Type: news

Markedly Elevated Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Markedly Elevated Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma
The risk of bone and soft-tissue sarcoma is markedly elevated in long-term survivors of hereditary retinoblastoma treated with radiation, researchers report.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - November 26, 2019 Category: Orthopaedics Tags: Hematology-Oncology News Source Type: news

An App That Can Catch Early Signs Of Eye Disease In A Flash
After his son developed a rare eye cancer, a chemist in Texas developed a smart phone app that uses a camera and artificial intelligence to detect early signs of eye disease.(Image credit: Munson et al., Sci. Adv. 2019; 5 eaax 6363) (Source: NPR Health and Science)
Source: NPR Health and Science - October 7, 2019 Category: Consumer Health News Authors: Joe Palca Source Type: news

Free app automatically looks for the 'white eye' cancer symptom in your phone's pictures
Scientists from Baylor University in Waco, Texas, ran the app on more than 52,000 'casual photographs' of 20 children with a range of eye conditions and 20 healthy controls. (Source: the Mail online | Health)
Source: the Mail online | Health - October 2, 2019 Category: Consumer Health News Source Type: news

How Wearing Sunglasses Actually Impacts Your Eyes, According to Science
When most people think about sun-related damage, they probably worry about their skin. But the sun’s ultraviolet rays also pose a threat to a person’s eyes. According to a 2014 study funded by the U.S. National Eye Institute, part of the National Institutes of Health, UV radiation can damage proteins in the eye’s lens. Over time, this damage can raise a person’s risk for cataracts, which impair vision. “When you don’t wear protection, ultraviolet radiation you cannot see is penetrating the eye, and the eye structures are very sensitive to it,” says Dr. Rebecca Taylor, a Nashville-b...
Source: TIME: Health - August 26, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Lifestyle Source Type: news

Coralberry: Natural treatment for eye cancer
(Natural News) Researchers in Germany found a way to slow down the progression of eye cancer. This may be possible through a substance found in the coralberry plant. Originating in Korea, the coralberry plant bears bright red fruits that make it a great ornamental plant. Its leaves contain bacteria that produce a natural insecticide called... (Source: NaturalNews.com)
Source: NaturalNews.com - August 19, 2019 Category: Consumer Health News Source Type: news

Moffitt researchers identify effective drug combination against uveal melanoma
(H. Lee Moffitt Cancer Center& Research Institute) Moffitt Cancer Center researchers have identified a new drug combination that is effective against metastatic uveal melanoma cells in preclinical studies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 8, 2019 Category: Cancer & Oncology Source Type: news

Tanzania: Medics Warn of Eye Cancer
[Daily News] MEDICAL experts in the country have raised considerable concern over raising cases of retinoblastoma, an eye cancer that develops in early childhood. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 20, 2019 Category: African Health Source Type: news

Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1
Malignancies arising from mutation of tumor suppressors have unexplained tissue proclivity. For example, BAP1 encodes a widely expressed deubiquitinase for histone H2A, but germline mutations are predominantly associated with uveal melanomas and mesotheliomas. We show that BAP1 inactivation causes apoptosis in mouse embryonic stem cells, fibroblasts, liver, and pancreatic tissue but not in melanocytes and mesothelial cells. Ubiquitin ligase RNF2, which silences genes by monoubiquitinating H2A, promoted apoptosis in BAP1-deficient cells by suppressing expression of the prosurvival genes Bcl2 and Mcl1. In contrast, BAP1 loss...
Source: ScienceNOW - April 17, 2019 Category: Science Authors: He, M., Chaurushiya, M. S., Webster, J. D., Kummerfeld, S., Reja, R., Chaudhuri, S., Chen, Y.-J., Modrusan, Z., Haley, B., Dugger, D. L., Eastham-Anderson, J., Lau, S., Dey, A., Caothien, R., Roose-Girma, M., Newton, K., Dixit, V. M. Tags: Genetics, Medicine, Diseases reports Source Type: news

Girl, 5, has her eye removed the day after doctors found 10 tumours in it
Gracie Corrigan, from Oregon, was diagnosed with the rare eye cancer retinoblastoma when doctors found 10 tumours around her right eye after her mother noticed it looked odd in a photo. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Plant compound could fight eye cancer
A toxin present in the coralberry plant can stop the division of cancer cells, a new study has found. The findings may lead to enhanced treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 28, 2019 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Targeting a common eye cancer
(Source: ScienceNOW)
Source: ScienceNOW - March 20, 2019 Category: Science Authors: Foley, J. F. Tags: twis Source Type: news

Mother, 23, detects her baby's eye cancer after seeing a bizarre spot in his pupil in a photograph
Specialists diagnosed Jaxson, then 11 months old, with a rare children's eye cancer. He needed surgery and chemo, but now, age three, he is in a stable condition. (Source: the Mail online | Health)
Source: the Mail online | Health - March 20, 2019 Category: Consumer Health News Source Type: news

Active substance from plant slows down aggressive eye cancer
(University of Bonn) An active substance that has been known for 30 years could unexpectedly turn into a ray of hope against eye tumors. This is shown by a study conducted by researchers from the Universities of Bonn and Magdeburg together with US colleagues. The results are published in the renowned journal 'Science Signaling'. The plant leaves of which contain the tested substance is anything but rare: At Christmas time you can find it in every well-assorted garden center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2019 Category: Cancer & Oncology Source Type: news

Direct targeting of G{alpha}q and G{alpha}11 oncoproteins in cancer cells
Somatic gain-of-function mutations of GNAQ and GNA11, which encode α subunits of heterotrimeric Gαq/11 proteins, occur in about 85% of cases of uveal melanoma (UM), the most common cancer of the adult eye. Molecular therapies to directly target these oncoproteins are lacking, and current treatment options rely on radiation, surgery, or inhibition of effector molecules downstream of these G proteins. A hallmark feature of oncogenic Gαq/11 proteins is their reduced intrinsic rate of hydrolysis of guanosine triphosphate (GTP), which results in their accumulation in the GTP-bound, active state. Here, we repor...
Source: Signal Transduction Knowledge Environment - March 18, 2019 Category: Science Authors: Annala, S., Feng, X., Shridhar, N., Eryilmaz, F., Patt, J., Yang, J., Pfeil, E. M., Cervantes-Villagrana, R. D., Inoue, A., Häberlein, F., Slodczyk, T., Reher, R., Kehraus, S., Monteleone, S., Schrage, R., Heycke, N., Rick, U., Engel, S., Pfeifer, Tags: STKE Research Articles Source Type: news

What makes a cell turn cancerous?
(Children's Hospital Los Angeles) CHLA researcher David Cobrinik, MD, PhD receives $1.6M grant to study how genetic changes cause retinoblastoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2019 Category: International Medicine & Public Health Source Type: news

Structure of the C-terminal guanine nucleotide exchange factor module of Trio in an autoinhibited conformation reveals its oncogenic potential
The C-terminal guanine nucleotide exchange factor (GEF) module of Trio (TrioC) transfers signals from the Gαq/11 subfamily of heterotrimeric G proteins to the small guanosine triphosphatase (GTPase) RhoA, enabling Gαq/11-coupled G protein–coupled receptors (GPCRs) to control downstream events, such as cell motility and gene transcription. This conserved signal transduction axis is crucial for tumor growth in uveal melanoma. Previous studies indicate that the GEF activity of the TrioC module is autoinhibited, with release of autoinhibition upon Gαq/11 binding. Here, we determined the crystal structur...
Source: Signal Transduction Knowledge Environment - February 19, 2019 Category: Science Authors: Bandekar, S. J., Arang, N., Tully, E. S., Tang, B. A., Barton, B. L., Li, S., Gutkind, J. S., Tesmer, J. J. G. Tags: STKE Research Articles Source Type: news

Virus-based therapy targets a pediatric eye cancer
(American Association for the Advancement of Science) A cancer-killing, virus-based therapy showed promising effects against retinoblastoma -- a tumor of the retina that affects mainly children -- in mouse models and a pilot clinical trial. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 23, 2019 Category: Cancer & Oncology Source Type: news